Subscribe to RSS

DOI: 10.1055/s-0045-1812012
Ramadan Fasting in Individuals with Diabetic Retinopathy: A Retrospective Cohort Study from the Diabetes and Ramadan Global Survey
Authors
Funding None.

Abstract
Background
Data on the impact of diabetic retinopathy (DR) on Ramadan fasting are limited. DR is not currently considered in pre-Ramadan risk stratification. However, its association with longer diabetes duration, poor glycemic control, and insulin use may increase vulnerability to adverse events during fasting.
Objectives
To evaluate fasting safety in patients with DR using data from the Diabetes and Ramadan (DaR) Global Survey.
Patients and Methods
This retrospective cohort study analyzed data from the DaR Global Survey conducted in 2020 and 2022 across multiple world regions. Patients with confirmed DR (DR group, n = 1,795) were compared with individuals without DR (control group, n = 10,735). Demographic and clinical data were collected through structured post-Ramadan clinic interviews. Primary outcomes included self-reported hypoglycemia, hyperglycemia, emergency visits, hospitalizations, and fasting interruption. Multivariate logistic regression was used to adjust for age, sex, diabetes duration, glycated hemoglobin (HbA1c), and insulin use.
Results
Individuals with DR had longer diabetes duration, comparable HbA1c, and greater insulin use compared with those without DR. DR was independently associated with a 45% lower likelihood of fasting during Ramadan (adjusted odds ratio [AOR]: 0.55, p ≤ 0.0001). Among those who fasted, hypoglycemia rates were similar in the DR (16.2%) and non-DR (14.6%) groups (p = 0.5), but hyperglycemia was more prevalent in DR (24.1 vs. 13.8%; p < 0.001). DR was also independently associated with breaking the fast due to hypoglycemia (AOR: 1.34), hypoglycemia requiring medical attention (AOR: 1.76), and hyperglycemia (AOR: 1.50).
Conclusions
DR was independently linked to lower fasting rates and higher risks of hypoglycemia, hyperglycemia, and medical interventions during Ramadan. These findings underscore the importance of incorporating DR assessment into fasting risk stratification tools to improve patient safety.
Keywords
diabetic retinopathy - Ramadan fasting - hypoglycemia - hyperglycemia - risk assessment - diabetes education - fasting complicationsAuthors Contributions
All authors contributed toward conception, data collection, writing, and final approval of the manuscript.
Compliance with Ethical Principles
Ethical approval was granted for the DAR Global Survey from Dubai Health Authority.
Publication History
Article published online:
16 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 2 Hou X, Wang L, Zhu D. et al; China National Diabetic Chronic Complications (DiaChronic) Study Group. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China. Nat Commun 2023; 14 (01) 4296
- 3 Mohamed Z, Al-Natour M, Al Rahbi H. Prevalence of diabetic retinopathy among individuals with diabetes in Gulf Cooperation Council countries: a systematic review and meta-analysis. Oman Med J 2024; 39 (01) e585
- 4 Bourne RRA, Jonas JB, Bron AM. et al; Vision Loss Expert Group of the Global Burden of Disease Study. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol 2018; 102 (05) 575-585
- 5 Group ETDRSR. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98 (5, Suppl): 786-806
- 6 Chai Q, Yao Y, Guo C, Lu H, Ma J. Structural and functional retinal changes in patients with type 2 diabetes without diabetic retinopathy. Ann Med 2022; 54 (01) 1816-1825
- 7 Gonzalez-Cortes JH, Martinez-Pacheco VA, Gonzalez-Cantu JE. et al. Current treatments and innovations in diabetic retinopathy and diabetic macular edema. Pharmaceutics 2022; 15 (01) 122
- 8 Urbančič M, Gardašević Topčić I. Dexamethasone implant in the management of diabetic macular edema from clinician's perspective. Clin Ophthalmol 2019; 13: 829-840
- 9 Tomita Y, Lee D, Tsubota K, Negishi K, Kurihara T. Updates on the current treatments for diabetic retinopathy and possibility of future oral therapy. J Clin Med 2021; 10 (20) 4666
- 10 Wong TY, Sabanayagam C. Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence. Ophthalmologica 2020; 243 (01) 9-20
- 11 Chew EY, Ambrosius WT, Davis MD. et al; ACCORD Study Group, ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363 (03) 233-244
- 12 Keech AC, Mitchell P, Summanen PA. et al; FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370 (9600): 1687-1697
- 13 Salti I, Bénard E, Detournay B. et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: EPIDIAR study. Diabetes Care 2004; 27 (10) 2306-2311
- 14 Hassanein M, Binte Zainudin S, Shaikh S. et al. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022. Curr Med Res Opin 2024; 40 (09) 1515-1523
- 15 Rübsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci 2018; 19 (04) 942
- 16 Li Y, Liu Y, Liu S. et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther 2023; 8 (01) 152
- 17 Beltramo E, Porta M. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem 2013; 20 (26) 3218-3225
- 18 Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 2018; 19 (06) 1816
- 19 Reilly T, Waterhouse J. Altered sleep-wake cycles and food intake: the Ramadan model. Physiol Behav 2007; 90 (2-3): 219-228
- 20 Lessan N, Ali T. Energy metabolism and intermittent fasting: the Ramadan Perspective. Nutrients 2019; 11 (05) 1192
- 21 Al-Rawi N, Madkour M, Jahrami H. et al. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: a prospective observational study. PLoS One 2020; 15 (08) e0237922
- 22 Nian S, Lo ACY, Mi Y, Ren K, Yang D. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis (Lond) 2021; 8 (01) 15
- 23 Harbuwono DS, Kurniawan F, Sudarsono NC, Tahapary DL. The impact of Ramadan fasting on glucose variability in T2DM patients. PLoS One 2020; 15 (06) e0234443
- 24 Bahijri S, Borai A, Ajabnoor G. et al. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS One 2013; 8 (04) e60917
- 25 Bahammam AS, Alaseem AM, Alzakri AA, Sharif MM. The effects of Ramadan fasting on sleep patterns and daytime sleepiness: an objective assessment. J Res Med Sci 2013; 18 (02) 127-131
- 26 American Diabetes Association Professional Practice Committee. 5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes-2025. Diabetes Care 2025; 48 (1, Suppl 1): S86-S127
- 27 Al-Arouj M, Assaad-Khalil S, Buse J. et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010; 33 (08) 1895-1902
- 28 Ajabnoor GM, Bahijri S, Borai A. et al. Health impact of fasting in Saudi Arabia during Ramadan: association with circadian rhythm and metabolic patterns. PLoS One 2014; 9 (05) e96500
- 29 Miyamoto K, Khosrof S, Bursell SE. et al. Prevention of leukostasis and vascular leakage via ICAM-1 inhibition in diabetic retinopathy. Proc Natl Acad Sci U S A 1999; 96 (19) 10836-10841
- 30 Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol 2012; 2012: 279037
- 31 Li H, Liu X, Zhong H. et al. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol 2023; 23 (01) 372